Goldman Sachs’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4M | Sell |
|
|||||
|
2025
Q1 | $13.5M | Sell |
|
|||||
|
2024
Q4 | $23.8M | Buy |
|
|||||
|
2024
Q3 | $38.8M | Sell |
|
|||||
|
2024
Q2 | $86.8M | Buy |
|
|||||
|
2024
Q1 | $97.4M | Buy |
|
|||||
|
2023
Q4 | $16.5M | Buy |
|
|||||
|
2023
Q3 | $2.01M | Sell |
|
|||||
|
2023
Q2 | $3.51M | Sell |
|
|||||
|
2023
Q1 | $3.4M | Buy |
|
|||||
|
2022
Q4 | $2.63M | Buy |
|
|||||
|
2022
Q3 | $844K | Sell |
|
|||||
|
2022
Q2 | $932K | Buy |
|
|||||
|
2022
Q1 | $1.14M | Buy |
|
|||||
|
2021
Q4 | $735K | Buy |
|
|||||
|
2021
Q3 | $261K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $542K | Sell |
|
|||||
|
2020
Q4 | $3.11M | Buy |
|